Micro Digital Co (305090) Fair Value & Analysis
Healthcare · KR · Market cap 36.3B KRW
Fair value as of: Aug 13, 2026
From 1 valuation models · updated today
Share price −13.0% over the past month.
Below-average quality, and screening another 79% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (481.63 KRW). The favourable scenario is already priced in.
- Weak quality (9/100) and above fair value at the same time, the margin of safety is missing on both counts.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
- A fairly wide model range (254.30 KRW to 481.63 KRW) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range 1,607 KRW – 18,550 KRW · fair‑value band 254.30 KRW – 481.63 KRW · the 1,826 KRW price screens above the 385.30 KRW fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Micro Digital Co (305090) currently trades at 1,826 KRW, while our model-based Fair Value estimate is 385.30 KRW, implying the stock looks roughly 78.9% overvalued today. The Quality Score stands at 9/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Trailing-twelve-month revenue stands at 12.8B KRW. Revenue declined 40.2% year over year. It earns a return on equity of -45.3%. Net debt stands at 6.7B KRW. Fundamentals as of Aug 13, 2026
Our scenario range runs from 254.30 KRW (bear case) to 481.63 KRW (bull case); at 1,826 KRW, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Healthcare peers we cover trades at -33% fair-value upside, at -79%, 305090 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 1 models by family
Notify me when 305090 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 15 · Market factors (momentum, volatility) 8
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Micro Digital Co., Ltd. develops, manufactures, and sells biomedical and bioprocess solutions in South Korea and internationally.
Full company description
Micro Digital Co., Ltd. develops, manufactures, and sells biomedical and bioprocess solutions in South Korea and internationally. The company offers biomedical lab instruments comprising Nabi, a UV/vis nano spectrophotometer; Mobi, a microplate spectrophotometer; Ubi-490, a UV/vis spectrophotometer; Ubi-600, a UV/vis standalone spectrophotometer; Ubi-800, a UV/vis double beam spectrophotometer; Lumi, a single tube luminometer; Lubi Plus, a microplate luminometer; and iSBS, an integrated sample banking system. It also provides biomedical in vitro diagnostic products consisting of DxBIC, an immunoassay automation platform. In addition, the company offers single-use bioreactor systems, such as CELBIC 5, CELBIC 25/50, CELBIC 100, CELBIC 200, CELBIC 500, and CELBIC 1000. Further, it provides bioprocess consumables, including 3D disposable cell culture bags; and 2D disposable storage, transfer, and sampling bags. The company serves CMOs and CDMOs, pharmaceutical companies, universities, research institutes, and alternative meat companies. Micro Digital Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Micro Digital Co reported revenue of 12.8B KRW in FY2025 versus 4.3B KRW in FY2021, a compound +31.4%/yr. Reported net income was −13.1B KRW in FY2025.
305090 screens 79% overvalued. Compare with Abbott Laboratories, →
Peer Group
Medical Devices · 349 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Abbott Laboratories, ABT | $110.91 | $74.79 | -33% |
| Stryker Corporation SYK | $347.21 | $186.28 | -46% |
| Medtronic plc MDT | $90.76 | $65.57 | -28% |
| Boston Scientific Corporation BSX | $51.42 | $38.44 | -25% |
| Edwards Lifesciences Corporation EW | $93.05 | $41.02 | -56% |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥153.60 | ¥147.63 | -4% |
| Shanghai United Imaging Healthcare Co 688271 | ¥110.50 | ¥43.60 | -61% |
| Demant A/S DEMANT | kr 289.60 | kr 161.17 | -44% |
| Getinge AB GETIB | kr 239.30 | kr 192.14 | -20% |
| Sectra AB SECTB | kr 280.00 | kr 66.81 | -76% |
Compare Micro Digital Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Micro Digital Co (305090) overvalued or undervalued?
What is the fair value of 305090?
What is the quality score of 305090?
What is the revenue of Micro Digital Co (305090)?
What is the net profit margin of 305090?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Micro Digital Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.